today announced that John Abele, Cofounder and former Co-Chairman of the multibillion-dollar
global medical device company, Boston Scientific, has joined the Nanobiosym
Global Advisory Board.
Over the past 30 years, Mr. Abele led the adoption of game-changing technologies
to enable new paradigms in healthcare such as angioplasty, therapeutic endoscopy,
and the use of catheters to treat vascular disease. A pioneer in the development
of “minimally invasive medicine,” Mr. Abele is a globally recognized
thought leader on technological, social and economic issues affecting healthcare.
“I am honored to welcome Mr. Abele to our Global Advisory Board,”
said Nanobiosym® Chairman and CEO, Dr. Anita Goel, MD, PhD - a Harvard and
MIT-trained physicist and physician. “I am inspired by his legacy which
provides us with a practical roadmap for bringing disruptive technologies to
market and creating entirely new ecosystems to drive cultural change in our
Nanobiosym has developed Gene-RADAR®, a portable nanotechnology platform
that can rapidly and accurately detect genetic fingerprints from any biological
organism. Dr. Goel’s vision is to give patients worldwide real-time access
to their own diagnostic information through low-cost handheld devices that could
detect disease from a single drop of blood or saliva.
“Nanobiosym’s technology platform is truly game-changing and has
the potential to radically redefine the rules of medical diagnosis.” Mr.
Abele said. “Dr. Goel’s approach to medicine through the lens of
physics and nanotechnology could bring about fundamental paradigm shifts in
modern medicine, possibly even quantum leaps in how we diagnose and heal diseases.
At Boston Scientific we fostered a culture of exploration and discovery and
I see that same drive and passion at Nanobiosym. I am delighted to join the
Nanobiosym Global Advisory Board, and I look forward to working very closely
with Dr. Goel and her team.” Mr. Abele joins Ratan Tata, Alfred Ford,
and Ambassador John Palmer on the Nanobiosym Global Advisory Board.
Named by MIT’s Technology Review as one of the world’s top science
and technology innovators working at the forefront of physics, biomedicine,
and nanotechnology, Dr. Goel has a passion for innovating holistically across
conventional disciplines. “We are deeply committed to bringing our scientific
innovations to address some of the greatest humanitarian needs and challenges
facing our planet,” said Dr. Goel.
“Dr. Goel’s vision for science is holistically shaped by the needs
of the greater good,” said Mr. Abele. “It is one thing to give the
world great science and technology. But it is even greater to have the vision
to use this science and technology to create a global impact that transcends
boundaries between scientific disciplines, between academia and industries,
and even between various geopolitical and socioeconomic arenas. Dr. Goel, a
rare blend of scientist, entrepreneur and visionary, is paving the path to a
better global future.”